Literature DB >> 9040934

Decreased immunoglobulin deposition in tumors and increased immature B cells in p53-null mice.

L Shick1, J H Carman, J K Choi, K Somasundaram, M Burrell, D E Hill, Y X Zeng, Y Wang, K G Wiman, K Salhany, T R Kadesch, J G Monroe, L A Donehower, W S el-Deiry.   

Abstract

Recent studies have hinted that there may be a relationship between p53 and the immune response. In preliminary experiments, we found significantly decreased levels of immunoglobulin deposition in 13 of 16 p53-null tumors compared with 2 of 17 tumors derived from p53 +/- mice. We further explored the effect of p53 on B-cell development and function. p53-null mice contained more splenic white pulp and more immature B cells in the bone marrow compared with p53 +/- mice. p53-null B cells were hyperresponsive to proliferative challenge but were not more resistant to signal-induced apoptosis. Several p53 DNA-binding sites were localized to the regulatory regions of immunoglobulin heavy and light chain genes, including the KII site, which serves as an enhancer for rearrangement of the mouse kappa chain J cluster genes. Levels of p53 protein and the kappa chain sterile transcript increased after exposure of pre-B cells to the DNA damaging agents etoposide and Adriamycin. Our observations suggest that p53 may be involved in B-cell maturation and may relay certain stress signals to affect B-cell function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9040934

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  9 in total

1.  A p53 axis regulates B cell receptor-triggered, innate immune system-driven B cell clonal expansion.

Authors:  Hyunjoo Lee; Shabirul Haque; Jennifer Nieto; Joshua Trott; John K Inman; Steven McCormick; Nicholas Chiorazzi; Patricia K A Mongini
Journal:  J Immunol       Date:  2012-05-18       Impact factor: 5.422

2.  p53 deficiency increases transformation by v-Abl and rescues the ability of a C-terminally truncated v-Abl mutant to induce pre-B lymphoma in vivo.

Authors:  X Zou; F Cong; M Coutts; G Cattoretti; S P Goff; K Calame
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  UV irradiation augments lymphoid malignancies in mice with one functional copy of wild-type p53.

Authors:  W Jiang; H N Ananthaswamy; H K Muller; A Ouhtit; S Bolshakov; S E Ullrich; A K El-Naggar; M L Kripke
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

4.  p53 mediates apoptotic crisis in primary Abelson virus-transformed pre-B cells.

Authors:  I Unnikrishnan; A Radfar; J Jenab-Wolcott; N Rosenberg
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

5.  CCAAT enhancer- binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy.

Authors:  L E Greenbaum; W Li; D E Cressman; Y Peng; G Ciliberto; V Poli; R Taub
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

6.  The tumour suppressor gene p53 modulates the severity of antigen-induced arthritis and the systemic immune response.

Authors:  M Leech; J R Xue; A Dacumos; P Hall; L Santos; Y Yang; M Li; A R Kitching; E F Morand
Journal:  Clin Exp Immunol       Date:  2008-03-12       Impact factor: 4.330

7.  Defective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23.

Authors:  David MacPherson; Jungho Kim; Teresa Kim; Byung Kirl Rhee; Conny Th M Van Oostrom; Richard A DiTullio; Monica Venere; Thanos D Halazonetis; Roderick Bronson; Annemieke De Vries; Mark Fleming; Tyler Jacks
Journal:  EMBO J       Date:  2004-09-02       Impact factor: 11.598

8.  Effects of prostaglandin E2 on p53 mRNA transcription and p53 mutagenesis during T-cell-independent human B-cell clonal expansion.

Authors:  Shabirul Haque; Xiao Jie Yan; Lisa Rosen; Steven McCormick; Nicholas Chiorazzi; Patricia K A Mongini
Journal:  FASEB J       Date:  2013-10-21       Impact factor: 5.191

9.  Roles of the tumor suppressor p53 and the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in receptor-mediated apoptosis of WEHI 231 B lymphoma cells.

Authors:  M Wu; R E Bellas; J Shen; G E Sonenshein
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.